← Leaderboards
Xinli Henry Lin
Genecopoeia, Inc.
$681,752
Attributed
$1,049,506
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $474.8K · FY2007–10$500K$375K$250K$125K$0
'07
'08
'09
'10
Funding mix
By agency
NIH$1,049,506 · 4
By mechanism
R44$735,508 · 1
R43$313,998 · 3
Top collaborators
- Luyuan Li2 shared
Others in their field
Top investigators on “Public Health Relevance”
- James Dennis Neaton · Northwestern University$207,438,295
- Sharon A Nachman · Johns Hopkins University$197,601,947
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,622,842
- Jeffrey P Krischer · University Of South Florida$163,793,528
- George R Seage · Abt Associates, Inc.$128,298,055
- Harry P Selker · Virginia Commonwealth University$123,247,735
Research focus
Public Health RelevanceBaseInclusion BodiesResistanceLungIn VitroTechnologyDrug FormulationsEscherichia ColiApoptosisInternational Agency For Research On CancerInnovationMalignant Neoplasm Of PancreasLegal PatentHead And Neck StructureAnimalsDiagnosisCancer TherapyColonDatabasesCell CycleCellsChimeric ProteinsDna Repair
Grant awards (5)
p53 Fusion Protein as an Oncology Therapeutic$367,754
R44 · FY2010 · CA · contact PI
Recombinant alpha1-Antitrypsin Therapeutics$107,000
R43 · FY2010 · HL · contact PI
p53 Fusion Protein as an Oncology Therapeutic$367,754
R44 · FY2009 · CA · contact PI
Mutant miniPlasmin for Treatment of Peripheral Arterial Occlusion$106,998
R43 · FY2009 · HL · contact PI
p53 Fusion Protein as an Oncology Therapeutic$100,000
R43 · FY2007 · CA · contact PI